The MELTF gene helps make a protein on the surface of some cells that appears to support how cells handle iron and interact with nearby tissue. If it does not work normally, cells may grow, move, or respond to their environment in less controlled ways. This gene plays an important role in research on cancer, especially melanoma, because changed MELTF activity has been linked to how some tumors behave.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some provide the directions for producing proteins, which do much of the work inside cells. Others mainly control when certain activities happen, where they happen, and how strongly they occur. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
MELTFGene function
What if the gene works
The MELTF gene makes melanotransferrin, a protein found on some cell surfaces and in blood. It helps cells interact with iron and may support normal cell growth and movement.
Risk
What if the gene does not work
Milder to more severe variants in the MELTF gene can reduce or alter melanotransferrin at the cell surface, which may affect iron handling and related cell signaling.
Treatment
What does that mean for your treatment
No MELTF-specific treatment or management approach is currently established for people with a pathogenic variant in the MELTF gene. In research, MELTF is being studied mainly as a cancer biomarker and possible drug target, rather than a marker that guides routine drug choices today.
Gene function
What if the gene works
MELTF helps your cells handle iron, a mineral your body needs every day. Its protein is found on the cell surface and can also be released outside the cell. A key part of MELTF gene function is supporting normal iron transport and iron balance in body tissues.
The MELTF gene makes a protein that can attach to iron at the cell surface. This helps keep iron available for controlled movement where cells need it.
When MELTF is working normally, cells can bring in some iron linked to this protein. That supports routine cell activity that depends on a steady iron supply.
Some MELTF protein is released into body fluids instead of staying on the cell surface. In that setting, it can help move iron through the space around cells.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MELTF gene can alter the melanotransferrin protein’s shape, stability, or the amount made by the cell. In practical terms, how MELTF gene variants affect protein structure and stability depends on the change: some are mild and slightly reduce stability or cell-surface placement, while more disruptive variants can shorten the protein or markedly lower how much the cell produces. These stronger changes may also weaken binding and other cell-level interactions.
How variants are linked to conditions
Current evidence on MELTF gene variants linked to conditions is still limited, and this gene does not yet have a broadly confirmed link to a specific health condition. If you have a reported MELTF gene finding, your clinician or genetic counselor can explain what it may mean for you as research continues to develop.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect natural variation among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the MELTF gene itself. If MELTF appears on a genetic test, its meaning depends on the exact change found and the wider clinical picture, so a doctor or genetic counselor can explain what it may mean for you or your family.
Inheritance of MELTF variants
There is not yet a broadly confirmed Mendelian pattern for how MELTF gene variants are inherited in a specific human condition. In other words, when people look at how MELTF gene variants are inherited, there is no single well-established dominant, recessive, or X-linked pattern to cite. The MELTF gene is located on chromosome 3, which is an autosome, so you inherit one copy from each parent.
What does my MELTF result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for the MELTF gene, though this can change as research develops. If you have a MELTF result and want to understand what it could mean for your family, a doctor or genetic counselor can help put it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
MELTF genetic testing uses a blood or saliva sample, and a lab reads the DNA code in the MELTF gene to look for variants. Results may show a benign variant, a variant of uncertain significance, or a variant linked to disease, which helps clarify whether a DNA change is likely relevant.
When should I consider getting a genetic test?
There isn't yet a broadly established reason to have genetic testing just for the MELTF gene. Decisions about testing are usually based on your own health, family history, and whether a doctor or genetic counselor thinks a broader genetic test could be helpful.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains varies by the condition and the type of variant involved. Many factors also shape how the body works over time, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood with other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. That helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way people respond to medicines. It studies the relationship between genes and drugs to better explain why the same treatment can work differently from one person to another. For many medications, genes influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the MELTF gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, treatment response, or new symptoms are best discussed with your doctor.
History
MELTF first drew attention in melanoma research, where scientists identified a cell surface protein called p97 that appeared in higher amounts on some melanoma cells than on many normal tissues. In the 1980s, this finding made MELTF part of efforts to understand how cancers could be recognized by distinctive markers. Building on this early work, scientists later showed that p97 belonged to the transferrin protein family and the gene became known as melanotransferrin, now written as the MELTF gene. As medical science evolved, so did understanding of this gene, including its presence in tissues beyond melanoma. Its history is mainly tied to cancer marker research rather than a widely known public story, but it remains a recognizable name in the scientific literature on melanoma.